SARS-CoV-2 mura A mura B Nucleic Acid hade
Sunan samfurin
Kayan Gano Haɗaɗɗen Acid na Nucleic (Fluorescence PCR)
Takardar Shaidar
AKL/TGA/CE
Ilimin Cututtuka
Cutar Kwayar Cutar Corona ta 2019 (COVID-19) tana faruwa ne sakamakon SARS-CoV-2 wanda ya samo asali daga β Coronavirus na wannan nau'in. COVID-19 cuta ce mai saurin yaɗuwa ta numfashi, kuma jama'a galibi suna cikin haɗarin kamuwa da ita. A halin yanzu, marasa lafiya da suka kamu da cutar SARS-CoV-2 sune babban tushen kamuwa da cutar, kuma marasa lafiya da ba su da alamun cutar suma na iya zama tushen kamuwa da cutar. Dangane da binciken da aka gudanar a yanzu, lokacin kamuwa da cutar shine kwanaki 1-14, galibi kwanaki 3-7. Manyan alamun cutar sune zazzabi, tari busasshe da gajiya. Wasu marasa lafiya suna da alamun kamar toshewar hanci, hanci mai gudu, ciwon makogwaro, ciwon myalgia da gudawa.
Mura cuta ce ta numfashi mai tsanani wadda kwayar cutar mura ke haifarwa. Tana yaduwa sosai kuma tana yaduwa ta hanyar tari da atishawa. Yawanci tana yaduwa a lokacin bazara da hunturu. Akwai nau'ikan Mura guda uku, Mura A (IFV A), Mura B (IFV B) da Mura C (IFV C), dukkansu suna cikin dangin ortomyxovirus. Mura A da B, waɗanda ƙwayoyin cuta ne na RNA masu rarrafe guda ɗaya, su ne manyan abubuwan da ke haifar da cututtukan ɗan adam. Mura A cuta ce mai saurin kamuwa da cutar numfashi, gami da H1N1, H3N2 da sauran nau'ikan, tana da sauƙin canzawa. Barkewar duniya, "canji" tana nufin maye gurbin mura A, wanda ke haifar da sabon "ƙananan nau'in kwayar cuta". Mura B ta kasu gida biyu: Yamagata da Victoria. Mura B tana da kwayar cutar antigenic kawai, kuma suna guje wa sa ido da kawar da tsarin garkuwar jikin ɗan adam ta hanyar maye gurbi. Amma ƙwayoyin cuta na mura B suna tasowa a hankali fiye da mura A ta ɗan adam, wanda kuma ke haifar da cututtukan numfashi da annoba a cikin mutane.
Tashar
| FAM | SARS-CoV-2 |
| ROX | IFV B |
| CY5 | IFV A |
| VIC (HEX) | Kwayoyin halittar Kulawa ta Ciki |
Sigogi na Fasaha
| Ajiya | Ruwa: ≤-18℃ A cikin duhu |
| Lyophilization: ≤30℃ a cikin duhu | |
| Tsawon lokacin shiryawa | Ruwa: Watanni 9 |
| Rushewar ƙwayoyin halitta: watanni 12 | |
| Nau'in Samfuri | Swab na nasopharyngeal, swab na oropharyngeal |
| Ct | ≤38 |
| CV | ≤5.0% |
| LoD | Kwafi 300/mL |
| Takamaiman Bayani | Sakamakon gwajin da aka yi ya nuna cewa kayan aikin sun dace da SARSr-CoV na coronavirus na ɗan adam, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, kwayar cutar syncytial ta numfashi A da B, kwayar cutar parainfluenza 1, 2 da 3, rhinovirusA, B da C, adenovirus 1, 2, 3, 4, 5, 7 da 55, kwayar cutar metapneumovirus ta ɗan adam, enterovirus A, B, C da D, kwayar cutar huhu ta ɗan adam, kwayar cutar EB, kwayar cutar kyanda kwayar cutar cytomegalovirus ta ɗan adam, rotavirus, norovirus, kwayar cutar mumps, kwayar cutar varicella zoster, kwayar cutar Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycobacterium tarin fuka, Aspergillus fumigatus, Candida albicans, Candida glabrata Babu wani haɗin kai tsakanin Pneumocystis yersini da Cryptococcus neoformans. |
| Kayan Aiki Masu Amfani: | Zai iya daidaita manyan kayan aikin PCR masu haske a kasuwa. Tsarin PCR na Zamani na Aiyuka 7500 Tsarin PCR Mai Sauri na Ainihin Lokaci Mai Amfani da Biosystems 7500 Tsarin PCR na Ainihin Lokaci na QuantStudio®5 Tsarin PCR na SLAN-96P na Gaskiya Tsarin PCR na LightCycler®480 na Ainihin Lokaci Tsarin Gano PCR na Layin Ganowa na Layin Ganowa na 9600 Plus na Lokaci-lokaci Mai Keke Mai Zafi na MA-6000 na Ainihin Lokaci Tsarin PCR na BioRad CFX96 na Ainihin Lokaci Tsarin PCR na BioRad CFX Opus 96 na Ainihin Lokaci |
Gudun Aiki
Zaɓi na 1.
Shawarar da aka ba da shawarar cirewa: Kit ɗin Macro & Micro-Test Viral DNA/RNA (HWTS-3001, HWTS-3004-32, HWTS-3004-48) da Macro & Micro-Test Automatic Nucleic Acid Extractor (HWTS-3006).
Zaɓi na 2.
Shawarar sinadarin cirewa: Cire sinadarin Nucleic Acid ko kuma sinadarin tsarkakewa (YDP302) daga Tiangen Biotech(Beijing) Co.,Ltd.






